Anti-leukemic effects of the V-ATPase inhibitor Archazolid A

Prognosis for patients suffering from T-ALL is still very poor and new strategies for T-ALL treatment are urgently needed. Our study shows potent anti-leukemic effects of the myxobacterial V-ATPase inhibitor Archazolid A. Archazolid A reduced growth and potently induced death of leukemic cell lines...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncotarget
Auteurs principaux: Zhang, Siwei, Schneider, Lina S., Vick, Binje, Grunert, Michaela, Jeremias, Irmela, Menche, Dirk, Müller, Rolf, Vollmar, Angelika M., Liebl, Johanna
Format: Artigo
Langue:Inglês
Publié: Impact Journals LLC 2015
Sujets:
Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4791247/
https://ncbi.nlm.nih.gov/pubmed/26496038
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires